<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1602">
 <bold>Conclusions:</bold> Standard enoxaparin dosing was shown to provide initial subtherapeutic anti-Xa levels in many patients with acute burn injury. In the overall study population, the enoxaparin dosing strategy was associated with a low incidence of VTE and bleeding complications.
</p>
